GMAB
Genmab A/S
$50.97−0.99 (−1.91%)Close Nov 18, 2026
Top holders
| Fund | %Weight (%) | Value |
|---|---|---|
| IBBiShares Biotechnology ETF | 1.1 | $102M |
| FBTFirst Trust NYSE Arca Biotechnology Index Fund | 2.6 | $73.8M |
| ALLIXAB Large Cap Growth Fund Class I | 0.2 | $46.5M |
| AVDEAvantis International Equity ETF | 0.1 | $18.1M |
| KAUFXFederated Hermes Kaufmann Fund Class R Shares | 0.3 | $15M |
| RETSXTax-Managed U.S. Large Cap Fund Class S | 0.1 | $9.88M |
| FNCMXFidelity Nasdaq Composite Index Fund | 0.0 | $2M |
| FTQIFirst Trust Nasdaq BuyWrite Income ETF | 0.2 | $1.74M |
| FILFXStrategic Advisers International Fund | 0.0 | $1.29M |
| APIEActivePassive International Equity ETF | 0.1 | $1.09M |
Holders
- Funds
- 20
- Held in all
- $274M
- Held by the top 10
- 99.0%
- Highest weight
- FBT2.6%